This investigation compound was initially documented by Hoffman-La Roche in 2009. It’s amongst several benzodiazepines within the imidazobenzodiazepine subgroup imagined to supply nootropic Advantages.Due to the position of ?five within the amnesic traits of other drugs, it’s believed the substantial specificity of the drug for these receptors